{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:40Z","timestamp":1772120020234,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470378"],"award-info":[{"award-number":["82470378"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515220038"],"award-info":[{"award-number":["2024A1515220038"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12012-025-09981-7","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:41:28Z","timestamp":1740750088000},"page":"582-591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management and Experiences in Diagnosing and Treating Acute Heart Failure in Children with Solid Tumors"],"prefix":"10.1007","volume":"25","author":[{"given":"Zizheng","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuandi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiufang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juncheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"9","key":"9981_CR1","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1111\/echo.14461","volume":"36","author":"J Akam-Venkata","year":"2019","unstructured":"Akam-Venkata, J., Kadiu, G., Galas, J., & Aggarwal, S. (2019). Pediatric malignancies: Is the prechemotherapy left ventricular function normal? Echocardiography, 36(9), 1727\u20131735. https:\/\/doi.org\/10.1111\/echo.14461","journal-title":"Echocardiography"},{"issue":"10","key":"9981_CR2","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s10554-018-1379-0","volume":"34","author":"M Tadic","year":"2018","unstructured":"Tadic, M., Baudisch, A., Ha\u00dffeld, S., et al. (2018). Right ventricular function and mechanics in chemotherapy- and radiotherapy-na\u00efve cancer patients. International Journal of Cardiovascular Imaging, 34(10), 1581\u20131587. https:\/\/doi.org\/10.1007\/s10554-018-1379-0","journal-title":"International Journal of Cardiovascular Imaging"},{"issue":"3","key":"9981_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cjca.2017.11.018","volume":"34","author":"M Tadic","year":"2018","unstructured":"Tadic, M., Genger, M., Baudisch, A., et al. (2018). Left ventricular strain in chemotherapy-naive and radiotherapy-naive patients with cancer. Canadian Journal of Cardiology, 34(3), 281\u2013287. https:\/\/doi.org\/10.1016\/j.cjca.2017.11.018","journal-title":"Canadian Journal of Cardiology"},{"issue":"8","key":"9981_CR4","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","volume":"17","author":"J Herrmann","year":"2020","unstructured":"Herrmann, J. (2020). Adverse cardiac effects of cancer therapies: Cardiotoxicity and arrhythmia. Nature Reviews Cardiology, 17(8), 474\u2013502. https:\/\/doi.org\/10.1038\/s41569-020-0348-1","journal-title":"Nature Reviews Cardiology"},{"key":"9981_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052912","author":"G Bertozzi","year":"2024","unstructured":"Bertozzi, G., Ferrara, M., Di Fazio, A., et al. (2024). Oxidative stress in sepsis: A focus on cardiac pathology. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms25052912","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"9981_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1200\/JCO.18.00313","volume":"37","author":"KD Getz","year":"2019","unstructured":"Getz, K. D., Sung, L., Ky, B., et al. (2019). Occurrence of treatment-related cardiotoxicity and its impact on outcomes among children treated in the AAML0531 clinical trial: A report from the children\u2019s oncology group. Journal of Clinical Oncology, 37(1), 12\u201321. https:\/\/doi.org\/10.1200\/JCO.18.00313","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl 3","key":"9981_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/oxfordjournals.ndt.a027970","volume":"15","author":"F Metivier","year":"2000","unstructured":"Metivier, F., Marchais, S. J., Guerin, A. P., Pannier, B., & London, G. M. (2000). Pathophysiology of anaemia: Focus on the heart and blood vessels. Nephrology, Dialysis, Transplantation, 15(Suppl 3), 14\u201318.","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"3","key":"9981_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/ajco.12782","volume":"14","author":"J Franzon","year":"2018","unstructured":"Franzon, J., Berry, N. M., Ullah, S., et al. (2018). Heart failure following blood cancer therapy in pediatric and adult populations. Asia-Pacific Journal of Clinical Oncology, 14(3), 224\u2013230. https:\/\/doi.org\/10.1111\/ajco.12782","journal-title":"Asia-Pacific Journal of Clinical Oncology"},{"issue":"5","key":"9981_CR9","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/MOP.0000000000000675","volume":"30","author":"N Bansal","year":"2018","unstructured":"Bansal, N., Amdani, S. M., Hutchins, K. K., & Lipshultz, S. E. (2018). Cardiovascular disease in survivors of childhood cancer. Current Opinion in Pediatrics, 30(5), 628\u2013638. https:\/\/doi.org\/10.1097\/MOP.0000000000000675","journal-title":"Current Opinion in Pediatrics"},{"issue":"3","key":"9981_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1470-2045(19)30800-9","volume":"21","author":"E Suh","year":"2020","unstructured":"Suh, E., Stratton, K. L., Leisenring, W. M., et al. (2020). Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: A retrospective cohort analysis from the childhood cancer survivor study. The lancet Oncology, 21(3), 421\u2013435. https:\/\/doi.org\/10.1016\/S1470-2045(19)30800-9","journal-title":"The lancet Oncology"},{"issue":"22","key":"9981_CR11","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1001\/jama.2013.6296","volume":"309","author":"MM Hudson","year":"2013","unstructured":"Hudson, M. M., Ness, K. K., Gurney, J. G., et al. (2013). Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA, 309(22), 2371\u20132381. https:\/\/doi.org\/10.1001\/jama.2013.6296","journal-title":"JAMA"},{"issue":"4","key":"9981_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/annonc\/mdf118","volume":"13","author":"LCM Kremer","year":"2002","unstructured":"Kremer, L. C. M., van Dalen, E. C., Offringa, M., & Vo\u00fbte, P. A. (2002). Frequency and risk factors of anthracycline-induced clinical heart failure in children: A systematic review. Annals of Oncology, 13(4), 503\u2013512.","journal-title":"Annals of Oncology"},{"issue":"2","key":"9981_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.54669","volume":"6","author":"CM Larsen","year":"2023","unstructured":"Larsen, C. M., Garcia Arango, M., Dasari, H., et al. (2023). Association of anthracycline with heart failure in patients treated for breast cancer or lymphoma, 1985\u20132010. JAMA Network Open, 6(2), e2254669. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.54669","journal-title":"JAMA Network Open"},{"issue":"12","key":"9981_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","volume":"104","author":"PA Henriksen","year":"2018","unstructured":"Henriksen, P. A. (2018). Anthracycline cardiotoxicity: An update on mechanisms, monitoring and prevention. Heart, 104(12), 971\u2013977. https:\/\/doi.org\/10.1136\/heartjnl-2017-312103","journal-title":"Heart"},{"issue":"2","key":"9981_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.5114\/aoms.2016.59270","volume":"12","author":"M Valcovici","year":"2016","unstructured":"Valcovici, M., Andrica, F., Serban, C., & Dragan, S. (2016). Cardiotoxicity of anthracycline therapy: Current perspectives. Archives of Medical Science, 12(2), 428\u2013435. https:\/\/doi.org\/10.5114\/aoms.2016.59270","journal-title":"Archives of Medical Science"},{"issue":"5","key":"9981_CR16","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/ijc.29468","volume":"137","author":"T Gudmundsdottir","year":"2015","unstructured":"Gudmundsdottir, T., Winther, J. F., de Fine, L. S., et al. (2015). Cardiovascular disease in adult life after childhood cancer in scandinavia: A population-based cohort study of 32,308 one-year survivors. International Journal of Cancer, 137(5), 1176\u20131186. https:\/\/doi.org\/10.1002\/ijc.29468","journal-title":"International Journal of Cancer"},{"issue":"1","key":"9981_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ccell.2016.11.011","volume":"31","author":"KA Sarosiek","year":"2017","unstructured":"Sarosiek, K. A., Fraser, C., Muthalagu, N., et al. (2017). Developmental regulation of mitochondrial apoptosis by c-Myc governs age- and tissue-specific sensitivity to cancer therapeutics. Cancer Cell, 31(1), 142\u2013156. https:\/\/doi.org\/10.1016\/j.ccell.2016.11.011","journal-title":"Cancer Cell"},{"issue":"1","key":"9981_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","volume":"31","author":"JV McGowan","year":"2017","unstructured":"McGowan, J. V., Chung, R., Maulik, A., Piotrowska, I., Walker, J. M., & Yellon, D. M. (2017). Anthracycline chemotherapy and cardiotoxicity. Cardiovascular Drugs and Therapy, 31(1), 63\u201375. https:\/\/doi.org\/10.1007\/s10557-016-6711-0","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"9981_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b4606","volume":"339","author":"DA Mulrooney","year":"2009","unstructured":"Mulrooney, D. A., Yeazel, M. W., Kawashima, T., et al. (2009). Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the childhood cancer survivor study cohort. BMJ, 339, b4606. https:\/\/doi.org\/10.1136\/bmj.b4606","journal-title":"BMJ"},{"issue":"14","key":"9981_CR20","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1200\/JCO.2008.21.1953","volume":"27","author":"L Diller","year":"2009","unstructured":"Diller, L., Chow, E. J., Gurney, J. G., et al. (2009). Chronic disease in the childhood cancer survivor study cohort: A review of published findings. Journal of Clinical Oncology, 27(14), 2339\u20132355. https:\/\/doi.org\/10.1200\/JCO.2008.21.1953","journal-title":"Journal of Clinical Oncology"},{"issue":"10386","key":"9981_CR21","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0140-6736(22)02471-0","volume":"401","author":"SB Dixon","year":"2023","unstructured":"Dixon, S. B., Liu, Q., Chow, E. J., et al. (2023). Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: A report from the Childhood Cancer Survivor Study cohort. Lancet, 401(10386), 1447\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(22)02471-0","journal-title":"Lancet"},{"issue":"7","key":"9981_CR22","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00246-018-1897-5","volume":"39","author":"SC Apostolopoulou","year":"2018","unstructured":"Apostolopoulou, S. C., Vagenakis, G. A., Tsoutsinos, A., Kakava, F., & Rammos, S. (2018). Ambulatory intravenous inotropic support and or levosimendan in pediatric and congenital heart failure: Safety, survival, improvement, or transplantation. Pediatric Cardiology, 39(7), 1315\u20131322. https:\/\/doi.org\/10.1007\/s00246-018-1897-5","journal-title":"Pediatric Cardiology"},{"issue":"2","key":"9981_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cardfail.2005.11.001","volume":"12","author":"JF Price","year":"2006","unstructured":"Price, J. F., Towbin, J. A., Dreyer, W. J., et al. (2006). Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure. Journal of Cardiac Failure, 12(2), 139\u2013143.","journal-title":"Journal of Cardiac Failure"},{"issue":"1","key":"9981_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1161\/CIRCHEARTFAILURE.114.001528","volume":"8","author":"BF Birnbaum","year":"2015","unstructured":"Birnbaum, B. F., Simpson, K. E., Boschert, T. A., et al. (2015). Intravenous home inotropic use is safe in pediatric patients awaiting transplantation. Circulation: Heart Failure, 8(1), 64\u201370. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001528","journal-title":"Circulation: Heart Failure"},{"key":"9981_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2023.06.004","author":"A Guzman-Gomez","year":"2023","unstructured":"Guzman-Gomez, A., Greenberg, J. W., Dani, A., et al. (2023). In the era of outpatient ventricular assist devices, is it time to reconsider the practice of bridging older children to transplant on outpatient inotropes? Journal of Thoracic and Cardiovascular Surgery. https:\/\/doi.org\/10.1016\/j.jtcvs.2023.06.004","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"issue":"23","key":"9981_CR26","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.1200\/JCO.2002.12.102","volume":"20","author":"SE Lipshultz","year":"2002","unstructured":"Lipshultz, S. E., Lipsitz, S. R., Sallan, S. E., et al. (2002). Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. Journal of Clinical Oncology, 20(23), 4517\u20134522.","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"9981_CR27","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1200\/JCO.2004.06.022","volume":"22","author":"JH Silber","year":"2004","unstructured":"Silber, J. H., Cnaan, A., Clark, B. J., et al. (2004). Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. Journal of Clinical Oncology, 22(5), 820\u2013828.","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"9981_CR28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/pbc.20351","volume":"44","author":"JH Silber","year":"2005","unstructured":"Silber, J. H. (2005). Role of afterload reduction in the prevention of late anthracycline cardiomyopathy. Pediatric Blood & Cancer, 44(7), 607\u2013613.","journal-title":"Pediatric Blood & Cancer"},{"issue":"36","key":"9981_CR29","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano, J. L., Lancellotti, P., Rodriguez Mu\u00f1oz, D., et al. (2016). 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the esc committee for practice guidelines: The task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (ESC). European Heart Journal, 37(36), 2768\u20132801. https:\/\/doi.org\/10.1093\/eurheartj\/ehw211","journal-title":"European Heart Journal"},{"issue":"14","key":"9981_CR30","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/eurheartj\/ehae105","volume":"45","author":"NV Sayour","year":"2024","unstructured":"Sayour, N. V., Pa\u00e1l, \u00c1. M., Ameri, P., et al. (2024). Heart failure pharmacotherapy and cancer: Pathways and pre-clinical\/clinical evidence. European Heart Journal, 45(14), 1224\u20131240. https:\/\/doi.org\/10.1093\/eurheartj\/ehae105","journal-title":"European Heart Journal"},{"issue":"12","key":"9981_CR31","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/ejhf.1985","volume":"22","author":"JL Zamorano","year":"2020","unstructured":"Zamorano, J. L., Gottfridsson, C., Asteggiano, R., et al. (2020). The cancer patient and cardiology. European Journal of Heart Failure, 22(12), 2290\u20132309. https:\/\/doi.org\/10.1002\/ejhf.1985","journal-title":"European Journal of Heart Failure"},{"issue":"12","key":"9981_CR32","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.healun.2004.03.018","volume":"23","author":"D Rosenthal","year":"2004","unstructured":"Rosenthal, D., Chrisant, M. R. K., Edens, E., et al. (2004). International society for heart and lung transplantation: Practice guidelines for management of heart failure in children. Journal of Heart and Lung Transplantation, 23(12), 1313\u20131333.","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"9","key":"9981_CR33","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","volume":"33","author":"R Kirk","year":"2014","unstructured":"Kirk, R., Dipchand, A. I., Rosenthal, D. N., et al. (2014). The international society for heart and lung transplantation guidelines for the management of pediatric heart failure: Executive summary. The Journal of Heart and Lung Transplantation, 33(9), 888\u2013909. https:\/\/doi.org\/10.1016\/j.healun.2014.06.002","journal-title":"The Journal of Heart and Lung Transplantation"},{"issue":"9","key":"9981_CR34","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","volume":"2","author":"J Butler","year":"2017","unstructured":"Butler, J., Anstrom, K. J., Felker, G. M., et al. (2017). Efficacy and safety of spironolactone in acute heart failure: The ATHENA-HF randomized clinical trial. JAMA Cardiol., 2(9), 950\u2013958. https:\/\/doi.org\/10.1001\/jamacardio.2017.2198","journal-title":"JAMA Cardiol."},{"issue":"15","key":"9981_CR35","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","volume":"370","author":"B Pitt","year":"2014","unstructured":"Pitt, B., Pfeffer, M. A., Assmann, S. F., et al. (2014). Spironolactone for heart failure with preserved ejection fraction. New England Journal of Medicine, 370(15), 1383\u20131392. https:\/\/doi.org\/10.1056\/NEJMoa1313731","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"9981_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ejhf.2726","volume":"25","author":"JP Ferreira","year":"2023","unstructured":"Ferreira, J. P., Cleland, J. G., Girerd, N., et al. (2023). Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: A pooled analysis of three randomized trials. European Journal of Heart Failure, 25(1), 108\u2013113. https:\/\/doi.org\/10.1002\/ejhf.2726","journal-title":"European Journal of Heart Failure"},{"issue":"7","key":"9981_CR37","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang, X., Wang, H., Han, D., et al. (2019). Ferroptosis as a target for protection against cardiomyopathy. Proceedings of the National Academy of Sciences, 116(7), 2672\u20132680. https:\/\/doi.org\/10.1073\/pnas.1821022116","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7784","key":"9981_CR38","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker, K., Hendricks, J. M., Li, Z., et al. (2019). The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature, 575(7784), 688\u2013692. https:\/\/doi.org\/10.1038\/s41586-019-1705-2","journal-title":"Nature"},{"issue":"21","key":"9981_CR39","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1200\/JCO.2004.02.034","volume":"22","author":"L Roffe","year":"2004","unstructured":"Roffe, L., Schmidt, K., & Ernst, E. (2004). Efficacy of coenzyme Q10 for improved tolerability of cancer treatments: A systematic review. Journal of Clinical Oncology, 22(21), 4418\u20134424.","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"9981_CR40","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12012-019-09547-4","volume":"20","author":"AFM Botelho","year":"2020","unstructured":"Botelho, A. F. M., Lempek, M. R., Branco, S. E. M. T., et al. (2020). Coenzyme Q10 cardioprotective effects against doxorubicin-induced cardiotoxicity in wistar rat. Cardiovascular Toxicology, 20(3), 222\u2013234. https:\/\/doi.org\/10.1007\/s12012-019-09547-4","journal-title":"Cardiovascular Toxicology"},{"issue":"4","key":"9981_CR41","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002639","volume":"9","author":"A Sharma","year":"2016","unstructured":"Sharma, A., Fonarow, G. C., Butler, J., Ezekowitz, J. A., & Felker, G. M. (2016). Coenzyme Q10 and heart failure: A state-of-the-art review. Circulation: Heart Failure, 9(4), e002639. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.115.002639","journal-title":"Circulation: Heart Failure"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-025-09981-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-025-09981-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-025-09981-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T02:30:37Z","timestamp":1741919437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-025-09981-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["9981"],"URL":"https:\/\/doi.org\/10.1007\/s12012-025-09981-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4566701\/v1","asserted-by":"object"}]},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}